ENANTA PHARMACEUTICALS INC's ticker is ENTA and the CUSIP is 29251M106. A total of 147 filers reported holding ENANTA PHARMACEUTICALS INC in Q4 2022. The put-call ratio across all filers is 0.02 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $286,315 | +18.7% | 7,080 | +36.5% | 0.01% | -18.2% |
| Q4 2022 | $241,206 | -23.9% | 5,185 | -15.2% | 0.01% | +10.0% |
| Q3 2022 | $317,000 | +3.3% | 6,116 | -6.5% | 0.01% | +11.1% |
| Q2 2022 | $307,000 | -28.8% | 6,544 | +5.1% | 0.01% | 0.0% |
| Q1 2022 | $431,000 | -5.9% | 6,227 | +1.4% | 0.01% | 0.0% |
| Q4 2021 | $458,000 | +10.6% | 6,143 | -16.8% | 0.01% | +12.5% |
| Q3 2021 | $414,000 | +58.6% | 7,381 | +23.9% | 0.01% | +100.0% |
| Q2 2021 | $261,000 | -12.1% | 5,957 | -3.6% | 0.00% | -20.0% |
| Q1 2021 | $297,000 | -26.8% | 6,179 | -36.7% | 0.01% | -44.4% |
| Q4 2020 | $406,000 | -19.4% | 9,766 | -13.1% | 0.01% | -43.8% |
| Q3 2020 | $504,000 | +76.8% | 11,244 | +93.2% | 0.02% | +60.0% |
| Q2 2020 | $285,000 | – | 5,820 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Krensavage Asset Management, LLC | 858,811 | $36,156,000 | 10.56% |
| Fairmount Funds Management LLC | 150,433 | $6,333,000 | 2.26% |
| ARMISTICE CAPITAL, LLC | 1,356,000 | $57,088,000 | 1.94% |
| FARALLON CAPITAL MANAGEMENT LLC | 1,775,000 | $74,728,000 | 0.45% |
| Virtus ETF Advisers LLC | 14,321 | $603,000 | 0.25% |
| Granahan Investment Management | 231,071 | $9,728,000 | 0.22% |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 248,320 | $10,454,000 | 0.09% |
| ACADIAN ASSET MANAGEMENT LLC | 467,514 | $19,684,000 | 0.08% |
| VIRTUS ALTERNATIVE INVESTMENT ADVISERS, INC. | 126 | $5,000 | 0.08% |
| AIGEN INVESTMENT MANAGEMENT, LP | 12,854 | $541,000 | 0.07% |